{{Rsnum
|rsid=9514828
|Gene=TNFSF13B
|Chromosome=13
|position=108269025
|Orientation=plus
|GMAF=0.3531
|Gene_s=TNFSF13B
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 32.7 | 41.6 | 25.7
| HCB | 29.6 | 54.1 | 16.3
| JPT | 33.0 | 40.2 | 26.8
| YRI | 89.8 | 9.5 | 0.7
| ASW | 70.2 | 28.1 | 1.8
| CHB | 29.6 | 54.1 | 16.3
| CHD | 31.2 | 52.3 | 16.5
| GIH | 22.8 | 39.6 | 37.6
| LWK | 82.7 | 17.3 | 0.0
| MEX | 56.9 | 39.7 | 3.4
| MKK | 63.5 | 33.3 | 3.2
| TSI | 18.6 | 56.9 | 24.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=23251602
|Title=Variation in dicer gene is associated with increased survival in T-cell lymphoma
|OA=1
}}

{{PMID Auto
|PMID=23845207
|Title=B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome
}}

{{PMID Auto
|PMID=19051265
|Title=Serum BLyS levels increase after rituximab as initial therapy in patients with follicular Grade 1 non-Hodgkin lymphoma.
|OA=1
}}

{{PMID Auto
|PMID=19383901
|Title=Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma.
|OA=1
}}

{{PMID Auto
|PMID=22338013
|Title=Cytokine BAFF gene variation is associated with survival of patients with T-cell lymphomas.
}}

{{PMID Auto
|PMID=22928528
|Title=Expression of genes involved in susceptibility to multifactorial autoimmune diseases: estimating genotype effects.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}